FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Authority Hl7

17,882 resources

Source: Text:

By Version

By Realm

 

Start Prev Rows 17600 - 17800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmSource(s)
us.nlm.vsacR42.16.840.1.113762.1.4.1235.575Kid Trans and Hx_HD_Clinical Grouping Condition_ICD10PCSactive2025-02uscms
us.nlm.vsacR42.16.840.1.113762.1.4.1235.576Kid Trans and Hx_HD_Clinical Grouping Condition_ICD9active2025-02usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1235.577Kid Trans and Hx_HD_Clinical Grouping Condition_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.270Triglyceride_Lab_Groupingactive2023-05usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.523UTI_Clinical_Condition_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.199Unknown Glucose_Event_ICD9active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1235.200Unknown Glucose_Event_ICD10active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1235.201Unknown Glucose_Event_LOINCactive2023-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.202Unknown Glucose_Event_CPTactive2023-01uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1235.203Unknown Glucose_Event_SNOMEDactive2023-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.613bwell Combo Blood Pressure Vitals_UI_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.614bwell Combo Blood Pressure Vitals_UI_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.609bwell Systolic Blood Pressure Vitals_UI_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.610bwell Systolic Blood Pressure Vitals_UI_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.611bwell Diastolic Blood Pressure Vitals_UI_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.612bwell Diastolic Blood Pressure Vitals_UI_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.441bwell_Vital_BMI_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.431bwell_Vital_Blood Glucose_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.437bwell_Vital_Blood Oxygen_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.509bwell_Vital_Blood Oxygen_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.541bwell_Vital_Blood Pressure Panel_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.438bwell_Vital_Systolic Blood Pressure_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.439bwell_Vital_Diastolic Blood Pressure_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.511bwell_Vital_Diastolic Blood Pressure_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.512bwell_Vital_Systolic Blood Pressure_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.513bwell_Vital_Systolic_and_Diastolic Blood Pressure_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.442bwell_Vital_Body Fat_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.444bwell_Vital_Body Height_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.445bwell_Vital_Body Weight_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.535bwell_Vital_Body Surface Area_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.536bwell_Vital_Body Surface Area_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.443bwell_Vital_Body Temperature_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.510bwell_Vital_Body Temperature_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.532bwell_Vital_Head Circumference_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.533bwell_Vital_Head Circumference_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.440bwell_Vital_Heart Rate_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.515bwell_Vital_Heart Rate_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.446bwell_Vital_Respiratory Rate_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.516bwell_Vital_Respiratory Rate_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.538bwell_Vital_Vital Signs Panel_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.539bwell_Vital_Vital Signs Panel_CPTactive2025-02uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1235.447bwell_Vital_Waist Circumference_LOINCactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.508bwell_Vital_Waist Circumference_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.5ADD/ADHD Conditionactive2025-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.344AFib (Atrial Fibrillation)_Clinical Condition Groupingactive2023-08usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.500Active Pregnancy_Clinical Grouping Eventactive2024-04usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.362Allergy List_Clinical Grouping Eventactive2023-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.20Annual Physical CN5active2023-04usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.436Anxiety_Clinical Grouping Conditionactive2024-04usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.253Asthma_Clinical Condition Groupingactive2023-05usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.424BMI >=30_Event_Clinical Condition Groupingactive2024-04usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.393BMI >=40_Event_Clinical Condition Groupingactive2024-04usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.453bwell_Vital_BMI_Clinical Grouping Eventactive2024-05usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.450bwell_Vital_Systolic Blood Pressure_Clinical Grouping Eventactive2024-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.413Birth Event_Clinical Grouping Eventactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.448bwell_Vital_Blood Glucose_Clinical Grouping Labactive2024-05usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.449bwell_Vital_Blood Oxygen_Clinical Grouping Eventactive2024-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.186Acute Inpatient_HD_Groupingactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.190Pregnancy_HD_Groupingactive2024-04usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.193ED Visit_HD_Groupingactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.542bwell_Vital_Blood Pressure Panel_Clinical Grouping Eventactive2024-08usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.454bwell_Vital_Body Fat_Clinical Grouping Eventactive2024-05usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.456bwell_Vital_Body Height_Clinical Grouping Eventactive2024-05usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.537bwell_Vital_Body Surface Area_Clinical Grouping Eventactive2024-08usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.455bwell_Vital_Body Temperature_Clinical Grouping Eventactive2024-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.457bwell_Vital_Body Weight_Clinical Grouping Eventactive2024-05usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.514bwell_Vital_Systolic_and_Diastolic Blood Pressure_Clinical Grouping Eventactive2024-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.558CABG_Clinical Grouping Conditionactive2024-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.588COPD_Clinical Condition Groupingactive2025-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.350COVID19 Vaccine_Event Clinical Groupingactive2023-08usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.375Cirrhosis_Groupingactive2023-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.318Colorectal Cancer_HD_Groupingactive2023-05usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.606Diastolic Blood Pressure_Compliantactive2025-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.605Systolic Blood Pressure_Compliantactive2025-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.359Coronary Artery Disease (CAD)_Clinical Condition Groupingactive2023-08usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.549Depression_Clinical Grouping Conditionactive2024-08usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.180Diastolic Blood Pressure_HDactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.182Remote Blood Pressure_HDactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.451bwell_Vital_Diastolic Blood Pressure_Clinical Grouping Eventactive2024-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.584Diastolic Less than 90_HD_Clinical Grouping Eventactive2024-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.94Cardiomyopathy Dilated Conditionactive2025-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.172End Stage Renal Disease (ESRD)_HD_Clinical Condition Groupingactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.567Essential HTN_HD_Clinical Grouping Conditionactive2024-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.571Total and Partial Neph_HD_Clinical Grouping Conditionactive2024-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.385Family History Hypertension (HTN)_Clinical Condition Groupingactive2024-05usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.406First Trimester_Clinical Grouping Eventactive2024-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.207Bone Marrow Transplant_HD_CN_Groupingactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.211Immunocompromising Conditions_HD_CN_Groupingactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.215Cerebrospinal Fluid Leak_HD_CN_Groupingactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.219Anatomic or Functional Asplenia_HD_CN_Groupingactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.222Sickle cell Anemia and HB S Disease_HD_CN_Groupingactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.237Cochlear Implant_HD_CN_Groupingactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.241Chemotherapy_HD_CN_Groupingactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.580HbA1c Level Less Than 8.0_HD_Clinical Grouping Conditionactive2024-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.534bwell_Vital_Head Circumference_Clinical Grouping Eventactive2024-08usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.265Heart Failure (CHF)_Clinical Condition Groupingactive2023-05usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.452bwell_Vital_Heart Rate_Clinical Grouping Eventactive2024-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.100Cardiomyopathy Hypertrophic Conditionactive2025-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.378IVF_Groupingactive2023-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.232Influenza Vaccine_HD_CN_Groupingactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.369Ischemic Vascular Disease (IVD)_Groupingactive2023-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.578Kid Trans and Hx_HD_Clinical Grouping Conditionactive2024-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.198Lipid Panel_Event_Groupingactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.520Lupus_Clinical Condition Groupingactive2025-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.553MI (Myocardial Infarction)_Clinical Grouping Conditionactive2024-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.372Muscular Pain and Disease_Groupingactive2023-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.417Obesity_Clinical Grouping Conditionactive2024-04usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.366Other Revascularization_Groupingactive2023-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.564PCI (Percutaneous Coronary Intervention)_Clinical Grouping Conditionactive2024-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.227Pneumococcal Vaccine_HD_CN_Groupingactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.593Polypharmacy_Clinical Condition Groupingactive2025-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.531Postpartum_Clinical Grouping Eventactive2024-08usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.382Pre_Hypertension (Pre_HTN)_Clinical Condition Groupingactive2024-04usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.504Prediabetes_Clinical Grouping Conditionactive2024-08usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.257Pregnancy Loss_HD_Clinical Condition Groupingactive2023-05usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.458bwell_Vital_Respiratory Rate_Clinical Grouping Eventactive2024-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.465Second Trimester_Clinical Grouping Eventactive2024-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.400Smoker Status_Event_Clinical Condition Groupingactive2024-04usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.176Systolic Blood Pressure_HDactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.583Systolic Less than 140_HD_Clinical Grouping Eventactive2024-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.468Third Trimester_Clinical Grouping Eventactive2024-04usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.204Unknown Glucose_Lab_Groupingactive2023-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.524UTI_Clinical Condition Groupingactive2024-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.540bwell_Vital_Vital Signs Panel_Clinical Grouping Eventactive2025-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.459bwell_Vital_Waist Circumference_Clinical Grouping Eventactive2024-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.617bwell Combo Blood Pressure_UIactive2025-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.616bwell Diastolic Blood Pressure_UIactive2025-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.615bwell Systolic Blood Pressure_UIactive2025-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.626b.well Herpes Zoster Vaccine CN_HD_Exclusionsactive2025-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.627b.well Herpes Zoster Vaccine CN_HD_Exclusions_SNOMEDactive2025-03ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.625b.well Herpes Zoster Vaccine CN_HD_2dose_SNOMEDactive2025-03ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.622b.well Herpes Zoster Vaccine CN_HD_2doseactive2025-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.618b.well Herpes Zoster Vaccine CN_HDactive2025-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1196.1358Beta lactam medicinal product SNOMEDactive2024-05ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.224Systolic Heart Failure I10active2025-03usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1235.647bwell Covid Vaccine CN_Allergy_SNOMEDactive2025-04ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1196.1354Cefixime preparations for oral administrationactive2024-05usrx
ch.fhir.ig.ch-lab-orderR4ServiceRequest.categoriesService Request Categories for Questionnairesactive2021-06chinternal
us.nlm.vsacR42.16.840.1.113762.1.4.1ONC Administrative Sexactive2015-03ustho
us.nlm.vsacR42.16.840.1.113762.1.4.1196.1352Body weightactive2024-05usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1260.58MMR Deficientactive2023-11ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1260.59MMR Deficientactive2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1260.60MMR Deficientactive2024-01usvsac
hl7.eu.fhir.idea4rcR4surgical-complications-eu-i4rcSurgical Complicationsactive2025-07eu
hl7.eu.fhir.idea4rcR4site-of-metastasis-i4rcSite of metastasisactive2025-07eu
hl7.eu.fhir.idea4rcR4beam-quality-i4rcBeam Qualityactive2025-07eu
hl7.fhir.uv.order-catalogR5bibliography-artifact-typeTypes of bibliographic artifactstrial-use2oo2019-12uvfhir
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1083Central DXA of Hip or Spineactive2018-03usloinc
ch.fhir.ig.ch-termR4ech-7-cantonflabbreviationeCH-0007 Canton Abbreviation incl. FL (Fürstentum Liechtenstein)active2025-05ch
ch.fhir.ig.ch-termR4ech-7-cantonabbreviationeCH-0007 Canton Abbreviationactive2025-05ch
ch.fhir.ig.ch-termR4ech-46-emailcategoryeCH-0046 Email Categoryactive2023-03ch
ch.fhir.ig.ch-termR4ech-46-internetcategoryeCH-0046 Internet Categoryactive2023-03ch
ch.fhir.ig.ch-termR4ech-46-phonecategoryeCH-0046 Phone Categoryactive2023-03ch
ch.fhir.ig.ch-termR4ech-10-linetypeeCH-010 Address Line Typeactive2018-11ch
ch.fhir.ig.ch-termR4ech-11-namedatatypeeCH-011 NameDataTypesactive2018-11ch
ch.fhir.ig.ch-termR4ech-11-firstnamedatatypeeCH-011 FirstNameDataTypesactive2018-11ch
ch.fhir.ig.ch-termR4ech-11-maritaldata-separationeCH-011 MaritalData Separationactive2020-10ch
ch.fhir.ig.ch-termR4ech-11-maritalstatuseCH-011 MaritalStatusactive2018-11ch
ch.fhir.ig.ch-termR4ech-11-sexeCH-011 Sexactive2018-11ch
hl7.fhir.uv.emedicinal-product-infoR5epiTypeePI document typesactive2025-07uvloinc
nhsd.assets.stu3R3ValueSet-eRS-APIErrorCode-1eRS API Error Codeactive2018-02
nhsd.assets.stu3R3ValueSet-eRS-Priority-1eRS Priorityactive2018-02
NHSDigital.FHIR.STU3R3ValueSet-eRS-ReviewReason-1eRS Review Reasonactive2021-03
uk.nhsdigital.r4.testR4ce41138f-5921-4e7d-98b9-acc90bc4edbfNHSDigital Workflow Codedraft2022-03
hl7.fhir.uv.toolsR5json-empty-behaviorJson Empty Behavior Codes Value Setinformative4fhir2025-08uvfhir
hl7.fhir.uv.cqmR4age-stratified-exampleAge Stratified Exampletrial-use4cqi2025-06uvtho
hl7.fhir.uv.cqmR4measure-stratifier-typeMeasure Stratifier Typetrial-use4cqi2025-06uvtho
us.nlm.vsacR42.16.840.1.113762.1.4.1196.4467Urogenital & Anorectal Specimensactive2024-05ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.87Intrauterine Devices SNOMED Findingsactive2021-10ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1065Chronic Liver Diseaseactive2024-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1067Chronic Liver Diseaseactive2022-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1196.4466Pharyngeal specimensactive2024-05ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1097Marfan's Syndromeactive2022-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.12.1009Cushings Syndromeactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1085Osteogenesis Imperfectaactive2022-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1087Osteogenesis Imperfectaactive2018-03usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1088Ankylosing Spondylitisactive2021-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1090Ankylosing Spondylitisactive2018-03usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1091Psoriatic Arthritisactive2018-03ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1093Psoriatic Arthritisactive2018-03usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1096Ehlers Danlos Syndromeactive2022-02usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1099Marfan's Syndromeactive2018-03usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1100Osteopeniaactive2018-08ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1102Osteopeniaactive2018-03usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1044Osteogenesis Imperfectaactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1045Ankylosing Spondylitisactive2023-12usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1046Psoriatic Arthritisactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1048Marfan's Syndromeactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1049Osteopeniaactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1023Cushings Syndromeactive2021-03ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1025Cushings Syndromeactive2018-03usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1026Lupusactive2023-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1028Lupusactive2018-03usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.12.1010Lupusactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1068Chronic Malnutritionactive2023-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1070Chronic Malnutritionactive2018-03usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.12.1036Chronic Malnutritionactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1021.120Patient Sex for Quality Measurementactive2024-10usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.12.1035Chronic Liver Diseaseactive2024-01usvsac
hl7.fhir.uv.ebmR6383075EvidenceVariable Handling Extension Value Setactive2025-08uv